pharmaceutical and related health care products on McKesson's GPO contract

McKesson has been awarded a contract by the State of Texas (Contract ID: HHSTX-6-000395586) effective February 19, 2026, for the provision of pharmaceutical and related healthcare products through McKesson's Group Purchasing Organization (GPO) contract. The contract encompasses a range of pharmaceutical products classified under NIGP Code 26972 (Miscellaneous Drugs and Pharmaceuticals). Specific product categories include allergenic extracts and pharmaceutical therapeutics designed to address various medical conditions.

The contract deliverables include five identified pharmaceutical products: alfalfa allergenic extract, horse epithelium allergenic extract, alder allergenic extract, vestronidase alfa, and naloxegol. These products span therapeutic categories for immunological treatments and pharmaceutical interventions. While specific contract values, cumulative amounts, and detailed performance periods were not provided in the award documentation, the GPO contract structure indicates that McKesson will serve as the primary distributor and supplier of these pharmaceutical products to eligible Texas healthcare entities and organizations requiring access to these therapeutic agents through the established Group Purchasing Organization framework.